F. Lisa Murtha
Senior Managing Director

Research Consulting, Compliance, Investigations, & Process Improvement

F. Lisa Murtha is a Senior Managing Director at Ankura with more than 30 years of healthcare, research, billing, fraud and abuse, HIPAA privacy, and compliance experience. Lisa leads the research practice, which provides operational and compliance consulting services to life sciences organizations, research sites, CROs, and investigators across the globe. She is based in Philadelphia.

  • Experience

    Prior to joining Ankura, Lisa served as the leader of the research practice at FTI Consulting where she served clients in areas such as research billing, research misconduct investigations, conflicts of interest matters, grants and contracts assessments, and general compliance program effectiveness assessments. Prior to that, she was a partner at Dentons US LLP, where she provided legal and consulting services to research sponsors and research sites, including negotiations of clinical trial agreements, and investigations and settlements of allegations of scientific fraud.

    Earlier in her career, Lisa worked as in-house counsel to two nationwide healthcare organizations, and served as the chief compliance officer for both Pennsylvania Blue Shield and the University of Pennsylvania and its health system.

    Lisa was a founding board member and officer of the Health Care Compliance Association and the Society of Corporate Compliance and Ethics. She is currently a faculty member of the Loyola Law School and the Drexel (Kline) School of Law, where she teaches research and general healthcare compliance courses.

    Lisa’s professional experience includes:

    • Development of coverage analyses and assessments of research billing practices at more than 50 of the country’s top research universities and health systems.
    • Conducted investigations and provided expert witness testimony into allegations of research/misconduct at several research universities.
    • Development and implementation of clinical trial offices at numerous universities and health systems.
    • Investigations into conflict of interest allegations at several healthcare organizations.
    • Provide interim CCO services for pharmaceutical and biotech companies.
    • Investigations and assessments for human research protection programs at numerous research universities and hospitals.
    • Assessment and process improvement consulting for the grants offices of several research universities.
    • Investigations into allegations of federal grant fraud.
    • Compliance program effectiveness assessments for numerous provider organizations.
    • Coding and billing audits for several of the nation’s top healthcare systems.


  • News & events
    • Lisa speaks regularly on research and compliance topics at conferences sponsored by the HCCA, SCCE, MAGI, PRIM&R, ACUA, and many more.
  • Insights & innovation
    • “The Regulation and Management of Clinical Research,” BNA, co-authored
    • “Conflicts of Interest and the Physician Patient Sunshine Provisions,” HCCA Compliance Today
    • “Healthcare Compliance Professional’s Guide to Clinical Trials,” HC Pro, co-authored
    • “Research Compliance Primer,” Aspen Publishers, co-authored with Patricia Brent
    • “Time and Effort Reporting – Just When You Thought It Was Safe To Go Outside,” The Journal of Health Care Compliance
    • “Research Compliance Monitoring Book (Auditing and Monitoring Research Organizations),” Jones & Bartlet Publishers
    • “Time and Effort Reporting – the Next Compliance Frontier,” BNA, Inc.
    • “Patient Safety Meets Corporate Compliance,” HCPro
    • “Clinical Trial Billing,” BNA
    • “Developing a Research Monitoring Plan,” Today’s Corporate Compliance
    • “Developing an HIPAA Monitoring Plan,” Today’s Corporate Compliance
    • “Human Subjects Protections,” The Journal of Healthcare Compliance
    • “A Children’s Hospital Perspective on Compliance,” Today’s Corporate Compliance
    • “Research Centers Enter New Era of Progress Balanced with Compliance: Sheltering Research Programs from Regulatory Policy Enforcement Swings,” The Journal of Healthcare Compliance co-authored with Rick Rohrbach, MBA, CPA
    • “Government Expands Its Focus To Include Quality Of Patient Care: How To Conduct A Patient Care Compliance Risk Assessment,” The Journal of Healthcare Compliance, co-authored with Diane Crowl Schwarz, RN, MBA
    • “Conducting an HIPAA Privacy Risk Assessment—Is It Too Early?” Today’s Corporate Compliance
    • “Effectiveness Measurement of Compliance Programs, Do You Really Need To Know?” Today’s Corporate Compliance
    • “The Compliance Code of Conduct and Beyond,” Corporate Compliance Officer-Opus Publications, co-authored with Lisa Horning
    • “Serial Billers’ and Underutilizers: Trends in Healthcare, Compliance,” The Legal Intelligencer, co-authored with Lisa Horning and Louis Picini
    • “The Wisdom of Corporate Compliance Programs,” Pennsylvania Bar Institute
    • “Corporate Compliance Programs, A Company’s Best Offense to a Qui Tam Action,” Business Development Associates
    • “The Role of the Insurer in an Integrated Delivery System, co-authored with Patricia Camvel,” Widener Law Symposium Journal
    • “Compliance Training, The Pennsylvania Blue Shield Cascading Training Approach,” Pennsylvania Bar Institute